Form 8-K - Current report:
SEC Accession No. 0000950170-25-084924
Filing Date
2025-06-11
Accepted
2025-06-11 17:07:57
Documents
10
Period of Report
2025-06-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K igms-20250606.htm   iXBRL 8-K 46726
  Complete submission text file 0000950170-25-084924.txt   160236

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20250606.xsd EX-101.SCH 32364
12 EXTRACTED XBRL INSTANCE DOCUMENT igms-20250606_htm.xml XML 4531
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 251040802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)